363 related articles for article (PubMed ID: 8688326)
1. C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.
Travis A; Pinder SE; Robertson JF; Bell JA; Wencyk P; Gullick WJ; Nicholson RI; Poller DN; Blamey RW; Elston CW; Ellis IO
Br J Cancer; 1996 Jul; 74(2):229-33. PubMed ID: 8688326
[TBL] [Abstract][Full Text] [Related]
2. c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study.
Gasparini G; Gullick WJ; Maluta S; Dalla Palma P; Caffo O; Leonardi E; Boracchi P; Pozza F; Lemoine NR; Bevilacqua P
Eur J Cancer; 1994; 30A(1):16-22. PubMed ID: 7908213
[TBL] [Abstract][Full Text] [Related]
3. c-erbB-2 oncoprotein expression in primary and advanced breast cancer.
Lovekin C; Ellis IO; Locker A; Robertson JF; Bell J; Nicholson R; Gullick WJ; Elston CW; Blamey RW
Br J Cancer; 1991 Mar; 63(3):439-43. PubMed ID: 1672254
[TBL] [Abstract][Full Text] [Related]
4. Expression of epidermal growth factor receptor in breast carcinoma.
Lewis S; Locker A; Todd JH; Bell JA; Nicholson R; Elston CW; Blamey RW; Ellis IO
J Clin Pathol; 1990 May; 43(5):385-9. PubMed ID: 2370306
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-erbB3 protein in primary breast carcinomas.
Naidu R; Yadav M; Nair S; Kutty MK
Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
[TBL] [Abstract][Full Text] [Related]
6. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
Poller DN; Hutchings CE; Galea M; Bell JA; Nicholson RA; Elston CW; Blamey RW; Ellis IO
Br J Cancer; 1992 Sep; 66(3):583-8. PubMed ID: 1355662
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables.
Binder C; Marx D; Overhoff R; Binder L; Schauer A; Hiddemann W
Ann Oncol; 1995 Dec; 6(10):1005-10. PubMed ID: 8750153
[TBL] [Abstract][Full Text] [Related]
8. c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival.
Quinn CM; Ostrowski JL; Lane SA; Loney DP; Teasdale J; Benson FA
Histopathology; 1994 Sep; 25(3):247-52. PubMed ID: 7821892
[TBL] [Abstract][Full Text] [Related]
9. c-erbB-3 protein expression in ovarian tumours.
Simpson BJ; Weatherill J; Miller EP; Lessells AM; Langdon SP; Miller WR
Br J Cancer; 1995 Apr; 71(4):758-62. PubMed ID: 7710941
[TBL] [Abstract][Full Text] [Related]
10. C-erbB-2 oncogene product expression depends on tumour type and is related to oestrogen receptor and lymph node status in human breast carcinoma.
Heatley M; Maxwell P; Whiteside C; Toner PG
Pathol Res Pract; 1993 Apr; 189(3):261-6. PubMed ID: 7687354
[TBL] [Abstract][Full Text] [Related]
11. C-erbB-2 overexpression in primary breast cancer: independent prognostic factor in patients at high risk.
Schönborn I; Zschiesche W; Spitzer E; Minguillon C; Möhner M; Ebeling K; Grosse R
Breast Cancer Res Treat; 1994; 29(3):287-95. PubMed ID: 7914107
[TBL] [Abstract][Full Text] [Related]
12. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
[TBL] [Abstract][Full Text] [Related]
13. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
[TBL] [Abstract][Full Text] [Related]
14. Is c-erb B-2 a predictor for recurrent disease in early stage breast cancer?
Pierce LJ; Merino MJ; D'Angelo T; Barker EA; Gilbert L; Cowan KH; Steinberg SM; Glatstein E
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):395-403. PubMed ID: 7903962
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
[TBL] [Abstract][Full Text] [Related]
16. Determination of c-erbB-2 protein in primary breast cancer tissue extract using an enzyme immunoassay.
Watanabe T; Fukutomi T; Tsuda H; Adachi I; Nanasawa T; Yamamoto H; Abe K
Jpn J Cancer Res; 1993 Dec; 84(12):1279-86. PubMed ID: 7904987
[TBL] [Abstract][Full Text] [Related]
17. The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer.
O'Reilly SM; Barnes DM; Camplejohn RS; Bartkova J; Gregory WM; Richards MA
Br J Cancer; 1991 Mar; 63(3):444-6. PubMed ID: 1672255
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status.
Umekita Y; Enokizono N; Sagara Y; Kuriwaki K; Takasaki T; Yoshida A; Yoshida H
Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):345-51. PubMed ID: 1348890
[TBL] [Abstract][Full Text] [Related]
19. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.
Wright C; Nicholson S; Angus B; Sainsbury JR; Farndon J; Cairns J; Harris AL; Horne CH
Br J Cancer; 1992 Jan; 65(1):118-21. PubMed ID: 1346366
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of immunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human breast cancer.
Schimmelpenning H; Eriksson ET; Falkmer UG; Rutqvist LE; Johansson H; Fallenius A; Auer GU
Eur J Surg Oncol; 1992 Dec; 18(6):530-7. PubMed ID: 1362164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
